Having trouble accessing articles? Reset your cache.

White House pushing Grassley-Wyden drug pricing bill, including inflation caps

Enacting drug pricing legislation by the end of December based on the Prescription Drug Pricing Reduction Act (PDPRA) is a top Trump administration priority, Joe Grogan, director of the White House Domestic Policy Council, said Friday at a press briefing. He also signaled that HHS will approve state drug importation plans, and expressed administration support for providing economic incentives to increase adoption of biosimilars.

While White House support is necessary for the enactment of drug pricing legislation, it is not certain that it will be sufficient. PDPRA is facing

Read the full 886 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers